Reversing cold tumors to hot: An immunoadjuvant-functionalized metal-organic framework for multimodal imaging-guided synergistic photo-immunotherapy

Zhijin Fan,Hongxing Liu,Yaohua Xue,Jingyan Lin,Yu Fu,Zhaohua Xia,Dongming Pan,Jian Zhang,Kun Qiao,Zhenzhen Zhang,Yuhui Liao
DOI: https://doi.org/10.1016/j.bioactmat.2020.08.005
IF: 18.9
2021-02-01
Bioactive Materials
Abstract:Immunotherapy assays using immunoadjuvants and tumor antigens could greatly increase the survival rates of patients with malignant tumors. As effective carriers, metal-organic frameworks (MOFs) have been widely utilized in cancer therapy due to their remarkable histocompatibility and low toxicity. Herein, we constructed a multimodal imaging-guided synergistic cancer photoimmunotherapy by employing a specific MOF (MIL101-NH<sub>2</sub>) as the core carrier; the MOF was dual-dressed with photoacoustic and fluorescent signal donors (indocyanine green, ICG) and immune adjuvants (cytosine-phosphate-guanine sequence, CpG) and named ICG-CpG@MOF. This nanocarrier could passively target the tumor site through the EPR effect and achieve multimodal imaging (fluorescence, photoacoustic, photothermal and magnetic resonance imaging) of the tumor. Synergistic cancer photoimmunotherapy was achieved via simultaneous photodynamic and photothermal methods with 808 nm laser irradiation. ICG-CpG@MOF achieved the GSH-controlled release of immunoadjuvant into the tumor microenvironment. Furthermore, the released tumor-associated antigen along with CpG could induce the transformation of tumor cells from cold to hot by activating the immune system, which significantly enhanced tumor cytotoxicity and achieved high cure rates with minimal side-effects. This strategy utilizing multimodal imaging and synergistic cancer photoimmunotherapy provides a promising approach for the diagnosis and treatment of cancer.
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?
### Problems the Paper Aims to Solve This paper aims to address several key issues in the treatment of malignant tumors and proposes a new therapeutic approach. Specifically: 1. **Improving Immune Response Rate**: Although cancer immunotherapy has made significant progress in recent years, there are still issues such as individual differences, low treatment response, and severe side effects. Therefore, improving the immune response rate and selectively destroying primary and metastatic tumors is an important goal. 2. **Multimodal Imaging-Guided Synergistic Photoimmunotherapy**: Utilizing metal-organic frameworks (MOFs) as carriers, combined with photoacoustic and fluorescence signal donors (indocyanine green, ICG) and immune adjuvants (CpG oligonucleotides), a multimodal imaging-guided synergistic photoimmunotherapy strategy has been developed. This method can passively target tumors through enhanced permeability and retention effect (EPR effect) and achieve multiple imaging modalities (fluorescence, photoacoustic, photothermal, and magnetic resonance imaging). 3. **Transforming Cold Tumors into Hot Tumors**: By activating the immune system, cold tumors can be transformed into hot tumors, thereby significantly enhancing tumor cytotoxicity, achieving high cure rates with minimal side effects. In summary, this paper provides a promising approach for cancer diagnosis and treatment by developing a multimodal imaging-guided synergistic photoimmunotherapy strategy.